Wolverine Trading, LLC Dynavax Technologies Corp Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$10.05 - $11.61 $217,080 - $250,776	21,600 New	21,600 $240,000
Q1 2024 May 15, 2024	BUY	$11.7 - $14.98 $374,400 - $479,360	32,000 New	32,000 $397,000
Q3 2023 Nov 15, 2023	BUY	$12.64 - $14.99 $289,456 - $343,271	22,900 New	22,900 $338,000
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $102,279 - $179,632	10,300 Added 25.06%	51,400 $529,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $306,195 - $527,313	41,100 New	41,100 $526,000
Q1 2022 May 16, 2022	SELL	$9.75 - $14.44 $640,575 - $948,708	-65,700 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $131,700 - $209,400	-10,000 Reduced 13.21%	65,700 $934,000
Q3 2021 Nov 12, 2021	BUY	$9.16 - $19.83 $334,340 - $723,794	36,500 Added 93.11%	75,700 $1.47 Million
Q2 2021 Aug 06, 2021	SELL	$7.25 - $10.99 $277,675 - $420,917	-38,300 Reduced 49.42%	39,200 $387,000
Q1 2021 May 14, 2021	BUY	$4.57 - $11.18 $110,137 - $269,438	24,100 Added 45.13%	77,500 $722,000
Q4 2020 Feb 12, 2021	BUY	$3.73 - $5.6 $13,428 - $20,160	3,600 Added 7.23%	53,400 $262,000
Q3 2020 Nov 13, 2020	BUY	$4.32 - $11.7 $215,136 - $582,660	49,800 New	49,800 $219,000
Q2 2020 Aug 13, 2020	SELL	$2.94 - $9.1 $76,734 - $237,510	-26,100 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$2.27 - $6.2 $41,995 - $114,700	-18,500 Reduced 41.48%	26,100 $93,000
Q4 2019 Feb 12, 2020	SELL	$3.46 - $6.93 $84,424 - $169,092	-24,400 Reduced 35.36%	44,600 $249,000
Q3 2019 Nov 14, 2019	BUY	$2.69 - $4.85 $52,993 - $95,545	19,700 Added 39.96%	69,000 $244,000
Q2 2019 Aug 20, 2019	SELL	$3.65 - $7.89 $13,505 - $29,193	-3,700 Reduced 6.98%	49,300 $197,000
Q1 2019 May 15, 2019	SELL	$7.08 - $12.09 $115,404 - $197,067	-16,300 Reduced 23.52%	53,000 $387,000
Q4 2018 Feb 14, 2019	BUY	$8.14 - $13.28 $39,072 - $63,744	4,800 Added 7.44%	69,300 $598,000
Q3 2018 Nov 14, 2018	BUY	$11.85 - $16.0 $299,805 - $404,800	25,300 Added 64.54%	64,500 $800,000
Q1 2018 May 15, 2018	BUY	$14.65 - $19.9 $84,970 - $115,419	5,800 Added 17.37%	39,200 $778,000
Q4 2017 Feb 14, 2018	SELL	$17.3 - $24.08 $570,900 - $794,640	-33,000 Reduced 49.7%	33,400 $625,000
Q3 2017 Nov 15, 2017	BUY	$15.2 - $21.5 $1.01 Million - $1.43 Million	66,400	66,400 $1.43 Million

Others Institutions Holding DVAX

# of Institutions

275

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

Black Rock Inc. New York, NY

21.9M
Shares

$283 Million
0.01% of portfolio
Deep Track Capital, LP Greenwich, CT

12.5M
Shares

$162 Million
5.15% of portfolio
Vanguard Group Inc Valley Forge, PA

9.22M
Shares

$119 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

8.33M
Shares

$107 Million
7.62% of portfolio
State Street Corp Boston, MA

7.69M
Shares

$99.2 Million
0.0% of portfolio

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.63B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account